Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT)

University Hospital Schleswig-Holstein (UKSH)

Status: Completed

Conditions: Prostate Cancer

Treatments: Radiation: Hypofractionated Radiosurgery

Study type: Interventional

Funder types: Other

Identifiers

NCT02635256

ZKS-121-003

ARO-2016-5 (Other Identifier)

Details and patient eligibility

About

Hypofractionated radiosurgery has been investigated in a few trials and appears to be safe and feasible.

Investigators initiated this multicenter phase II prospective trial to analyse feasibility (toxicity) of hypofractionated radiosurgery with 5 fractions in patients with localised prostate cancer, who are ineligible for the "PREFERE trial" under the hypothesis that the ratio of patients with late toxicity ≥ grade 2 after 1 year amounts 2,8% and is significant lower than 17.5%.

Full description

Experimental radiosurgery of prostate with 5 fractions each with 7,00 Gy (total application rate of 35,00 Gy).

Planned visits are: Baseline, visits at every radiation day and four follow ups (4-6 weeks, 3 months, 6 months and one year after last day of radiation).

Enrollment: 85 patients

Sex: Male

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Localised, histopathologically confirmed Prostate Cancer (cT1-3 N0 M0)
• Gleason-grade ≤7
• Guideline-based staging
• Age ≥ 60 years
• PSA < 15 ng/ml
• Volume of the prostate <80 cm³
• IPSS-Score ≤12
• Written informed consent

Exclusion criteria

• History of prior pelvic radiotherapy
• Contraindication to MRI or Fiducial marker implantation (e.g. allergy to gold),
• Immunosuppressive therapy
• Relevant comorbidity thought to adversely affect treatment compliance,
• Legal incapacity or lack of informed consent

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

85 participants in 1 patient group

Hypofractionated Radiosurgery

Experimental group

Description:

5 fractions with 7 Gy, total dose 35 Gy

Treatment:

Radiation: Hypofractionated Radiosurgery